Contact Us

DESTINATION NEWS

SIG TAX & ACCOUNTING PTE LTD (SIG Global) Wins Singapore Prestige Brand Award 2024

Feb 19, 2025

SINGAPORE,Feb. 18,2025-- SIG Global,a leading provider of comprehensive globalisation solutions,has been honored with the Singapore Prestige Brand Award (SPBA) 2024. This recognition highlights the co

MYKAPITAL OFFICIALLY LAUNCHES WITH STRATEGIC PARTNERSHIPS TO DIGITISE INTEREST SCHEME MANAGEMENT

Feb 19, 2025

KUALA LUMPUR,Malaysia,Feb. 18,2025-- In a landmark move towards digitalising interest scheme management,MyKapital Platform Sdn Bhd,a subsidiary of Masverse Holdings Sdn Bhd(a Malaysian blockchain ecos

Mega Matrix Inc. Announced that the Royal Comeback Drama "From Lost Heiress to Royal Highness" Now Streaming on FlexTV

Feb 19, 2025

SINGAPORE,Feb. 18,2025-- Mega Matrix Inc. (NYSE American: MPU)\'s global leading short-drama streaming platform,FlexTV,launched the new series From Lost Heiress to Royal Highness on January 24. This

TUMI CELEBRATES 50TH ANNIVERSARY WITH CAMPAIGN, "MADE FOR YOU SINCE 1975"

Feb 19, 2025

With the customer as their muse,the brand showcases their icons and looks to the future NEW YORK,Feb. 18,2025-- Today,international travel and lifestyle brand TUMI launches its milestone 50th anniver

Joint Statement by Saudi Finance Minister and IMF Managing Director on Supporting Recovery in the Middle East's Conflict-Affected Economies

Feb 18, 2025

ALULA,Saudi Arabia,Feb. 17,2025-- On the sidelines of the inaugural annual global AlUla Conference for Emerging Market Economies in Al Ula,Saudi Arabia (February 16-17),Saudi Arabia\'s Finance Ministr

ASCO GU|RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disitamab Vedotin plus Immunotherapy as Perioperative Regimen for Bladder Cancer

Feb 18, 2025

YANTAI,China,Feb. 15,2025-- On the morning of February 14,2025 (UTC-8),at the ongoing 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) held in San Francisco,USA,Pr

1 ... 83 84 85 86 87 88 89 ... 338